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Abstract
Background: RhoGDI proteins are important regulators of the small GTPase Rac, because they shuttle Rac from the
cytoplasm to membranes and also protect Rac from activation, deactivation and degradation. How the binding
and release of Rac from RhoGDI is regulated is not precisely understood.
Results: We report that the non-receptor tyrosine kinase Fer is able to phosphorylate RhoGDIa and form a direct
protein complex with it. This interaction is mediated by the C-terminal end of RhoGDIa. Activation of Fer by
reactive oxygen species caused increased phosphorylation of RhoGDIa and pervanadate treatment further
augmented this. Tyrosine phosphorylation of RhoGDIa by Fer prevented subsequent binding of Rac to RhoGDIa,
but once a RhoGDIa-Rac complex was formed, the Fer kinase was not able to cause Rac release through tyrosine
phosphorylation of preformed RhoGDIa-Rac complexes.
Conclusions: These results identify tyrosine phosphorylation of RhoGDIa by Fer as a mechanism to regulate
binding of RhoGDIa to Rac.
Background
Rac proteins belong to the larger family of Rho GTPases
that act as molecular switches. When bound to GTP,
they are in an active conformation. Hydrolysis of GTP
to GDP causes an inactivating conformational change.
Racs are post-translationally modified by the removal of
C-terminal amino acid residues, followed by the attach-
ment of a lipid moiety in the form of a geranyl-geranyl
group [1].
Because of this modification, mature Rac proteins are
lipophilic and are only present in the cytosol when
bound to the chaperone and transport protein
RhoGDI. RhoGDI regulates the movement of Rac
between the cytosol and membranes. Moreover, a
recent study showed that Rho proteins compete for
binding to a limited pool of R h o G D I ,w h i c h ,o n c ei t
has bound them, provides stabilization and protection
from degradation [2].
There are only three distinct RhoGDI proteins, of
which RhoGDIa is the most ubiquitously expressed.
The structure of RhoGDI bound to small GTPases has
been elucidated. Rac makes contact with both N-and
C-terminal regions in RhoGDI, with its hydrophobic tail
fitting into a pocket in the C-terminal part of RhoGDI.
However, the exact mechanism by which binding and
release of Racs from RhoGDI is mediated is not well
known [3,4].
RhoGDI can be phosphorylated on serine S101 and
S174 by the serine/threonine kinase Pak [5] and PKCa
also phosphorylates RhoGDIa, on residue S96 [6]. Inter-
estingly, constitutively activated oncogenic Src, which
has a deregulated tyrosine kinase activity, was shown to
phosphorylate RhoGDIa on tyrosine residue Y156 [7].
In the current study we report that a normal cellular
tyrosine kinase which is member of the Src family, Fer,
is able to specifically tyrosine phosphorylate RhoGDIa
and that this can regulate the binding to Rac1.
Results and discussion
The BCR/ABL oncogene encodes a chimeric protein
that contains most of the Abl tyrosine kinase. Proteomic
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changes in phosphorylation of RhoGDI. To investigate if
the deregulated Bcr/Abl tyrosine kinase, similar to onco-
genic Src [7], is able to modify RhoGDIa, we performed
an immunocomplex kinase assay with cells expressing
Bcr/Abl or with Fer, a non-receptor tyrosine kinase
related to Abl, in the presence of added recombinant
GST-RhoGDIa or control GST. As shown in Figure 1A,
left panel, the Bcr/Abl protein exhibited strong autopho-
sphorylation activity, as expected. However, there was
very little phosphorylated RhoGDIa. In contrast, there
was a prominent signal of phosphorylated RhoGDIa in
the sample expressing Fer (Figure 1A right panel).
To examine whether Fer and RhoGDIa interact in
cells, we transfected COS-1 cells with pEGFP-Fer (wild
type, WT) or kinase dead D742R mutant pEGFP-Fer
(mutant, MT), with or without RhoGDIa and investi-
gated possible protein complex formation between these
by co-immunoprecipitation. As shown in Figure 1B, left
panel, Fer-WT clearly co-immunoprecipitated with
RhoGDIa, which was phosphorylated on tyrosine, as
judged by Western blotting using phosphotyrosine anti-
bodies. In the converse experiment (Figure 1B, right
panel, Fer IP) we confirmed the interaction between
Fer-WT and RhoGDIa. In the presence of the Fer
mutant lacking tyrosine kinase activity, no tyrosine
phosphorylated RhoGDIa was detected, indicating that
Fer tyrosine kinase activity is directly or indirectly
needed to generate tyrosine phosphorylated RhoGDIa.
Interestingly, the kinase-defective Fer protein exhibited
a reduced ability to form a complex with RhoGDIa
(compare lanes in IP Fer, IB for RhoGDIa), suggesting
that the binding of these two proteins is facilitated by
tyrosine phosphorylation. This is in agreement with the
finding that the isolated Fer SH2 domain binds to
RhoGDIa on far-Western blots (not shown). Impor-
tantly, we also were able to co-immunoprecipitate endo-
genous Fer with endogenous RhoGDIa in a lysate of the
mast cell line RBL-2H3. This indicates that the complex
formation between RhoGDIa and Fer also takes place
without overexpression (Figure 1C).
Although reactive oxygen species (ROS) were origin-
ally identified as a bactericidal mechanism, a role for
H2O2 as secondary messenger has now been well-
established. Many groups suggest that Src may be a pri-
mary target of ROS, with some studies reporting activa-
tion of Src kinase activity upon ROS exposure [9]. Since
constitutively activated oncogenic Src had been shown
to phosphorylate RhoGDIa [10,11], we tested if expo-
sure of c-Src to H2O2 would activate it to phosphorylate
RhoGDIa.A ss h o w ni nF i g u r e2 A ,i nt h ep r e s e n c eo f
c-Src and after H2O2 exposure, we could detect tyrosine
phosphorylated RhoGDIa. Sangrar et al [12] showed
that ROS also induce Fer tyrosine autophosphorylation
as well as trans-phosphorylation activity. As shown in
Figure 2B, we confirmed Fer activation by H2O2 in dif-
ferent types of cells by immunoprecipitation and Wes-
tern blotting with anti-phosphotyrosine antibodies. In
addition, when we co-transfected Fer with RhoGDIa
and treated the cells with H2O2, increased RhoGDIa
tyrosine phosphorylation was detected (Figure 2C). The
tyrosine phosphorylated RhoGDIa was visible as two
discrete bands, indicating this protein is subject to pro-
cessive phosphorylation.
Tyrosine phosphorylation of signal transduction pro-
teins in the absence of an oncogenic, constitutively acti-
vated tyrosine kinase may be difficult to detect due to
the transient nature of the phosphorylation and the
activity of phosphatases. Wang et al. reported that per-
vanadate treatment allows detection of phosphorylation
on RhoGDIa because this inhibits protein-tyrosine
phosphatases and traps proteins in their tyrosine-phos-
phorylated form [13]. Next, we examined if pervanadate
would further activate Fer and increase RhoGDIa tyro-
sine phosphorylation. As shown in Figure 3A, when
cells co-expressing RhoGDIa and Fer were exposed to
pervanadate for 5 minutes, a marked increase in tyrosine
phosphorylation was seen both in Fer and RhoGDIa
proteins (Figure 3A). The N-terminal regulatory domain
of RhoGDI binds to the switch region of Rac whereas
the C-terminal end adopts a conformation that accom-
modates the hydrophobic tail of Rac [6]. To examine
which domain interacts with Fer, we expressed the
N- and C-terminus of RhoGDIa as Xpress-tagged pro-
teins, together with Fer, and immunoprecipitated each
fragment of RhoGDIa with Xpress antibodies. We could
not detect a clear interaction of the N-terminal end
with Fer (data not shown). As shown in Figure 3B
(RhoGDIa-CT + Fer), in immunoprecipitates with the
C-terminal end of RhoGDIa and in the presence of per-
vanadate, we recovered tyrosine-phosphorylated Fer.
Moreover, this domain of RhoGDIa also was tyrosine
phosphorylated (Figure 3B). This indicates that Fer
interacts with and tyrosine phosphorylates residues in
the part of RhoGDIa that includes the domain that
binds to the C-terminal end of Rac. We were also able
to demonstrate that endogenous RhoGDIa was phos-
phorylated on tyrosine in response to pervanadate,
which activates Fer in RBL-2H3 cells (Figure 3C).
We used purified proteins to examine if tyrosine phos-
phorylation of RhoGDIa could regulate its ability to bind
Rac. Fer was expressed as a GST fusion protein in bacu-
lovirus. In Figure 4A (left panel), we first incubated GST-
RhoGDIa with Rac to allow these proteins to form a
complex. Then GST-Fer or control GST was added with
a kinase reaction buffer and the kinase reaction was
initiated. As shown in the top panel (pY20 blot), both
autophosphorylation of Fer and transphosphorylation of
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Page 2 of 7Figure 1 Fer forms a complex with RhoGDIa and phosphorylates it on tyrosine.( A )C O S - 1c e l l sw e r et r a n s f e c t e dw i t hB c r / A b lo rF e r
(pSG5-Fer). Autoradiogram of immune complex kinase reaction performed with immunoprecipitated Bcr/Abl or Fer (CH-6 antibodies) as
indicated, with bacterially expressed GST-RhoGDIa or control GST added. (B) Immunoprecipitation (IP) from cells transfected with pEGFP tagged-
Fer-WT or Fer-MT alone or together with RhoGDIa using RhoGDIa antibodies (Santa Cruz) (left panel) or Fer monoclonal rat antiserum (right
panel). Antibodies used for immunoblot (IB) are indicated below the panels. After reaction with the pY20 antibodies, blots were stripped and
reacted with RhoGDIa (Santa Cruz) or GFP antibodies. Arrowheads point to the locations of Fer and RhoGDIa. Molecular weight standards are in
kDa. (C) Co-immunoprecipitation of endogenous Fer (using antibodies from Abcam) and RhoGDIa (Santa Cruz antibodies) proteins in RBL-2H3
mast cell lysates. These results are representative of three independent experiments.
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Page 3 of 7RhoGDIa occurred as expected. However, there was no
evidence that Rac was tyrosine phosphorylated (not
shown). Rac protein was recovered in immunoprecipitates
from both Fer-treated and non-Fer treated samples, indi-
cating that the presence or absence of Fer does not affect
preformed Rac-RhoGDIa complexes. A different result
was obtained when Fer was first incubated with RhoG-
DIa and a kinase reaction was done. When Rac was sub-
sequently added and allowed to bind, we found that it
was not co-immunoprecipitated with RhoGDIa in the
Fer-treated sample (Figure 4B). The lack of binding of
Rac to RhoGDIa could be because tyrosine-phosphory-
lated RhoGDIa has decreased affinity for Rac, or because
the binding of Fer to RhoGDIa prevented subsequent
binding of Rac to RhoGDIa. Interestingly, this effect is
similar to that reported for oncogenic Src: when Src
phosphorylated RhoGDIa, the affinity of RhoGDIa for
Rac was also significantly reduced [7].
Conclusions
Tyrosine phosphorylation as a mechanism to regulate
RhoGDIa has not been widely investigated, although it
was recently reported that pervanadate treatment of a
pancreatic islet beta cell line caused the appearance of
phosphotyrosine on RhoGDIa and was accompanied by
lack of Cdc42 binding [13]. There is also increasing evi-
dence that H2O2 regulates the balance of tyrosine phos-
phorylation and de-phosphorylation in cells. The
current study shows that non-oncogenic tyrosine kinases
are likely to play a role in regulating the binding of Rac
GTPases to RhoGDIa and through this, the cellular
pool of Rac.
Methods
Antisera and DNA constructs
The Fer polyclonal rabbit anti-Fer CH-6 antiserum
[14,15] and anti-Fer monoclonal rat antiserum [16] have
been previously described and were used for immuno-
precipitation. RhoGDIa antibodies were obtained from
Upstate Biotechnology (Temecula, CA) or Santa Cruz
(Santa Cruz, CA). Antibodies against Fer, GFP, Xpress
and GST were from Abcam (San Francisco, CA), Santa
Cruz, Invitrogen (Carlsbad, CA) and Santa Cruz, respec-
tively. Antibodies against pY20 and Rac1 were
purchased from BD Bioscience (Franklin Lakes, NJ).
pSG5-Fer was constructed by subcloning a 2.9 kb
BamHI fragment from human Fer clone L3, encompass-
ing the entire coding region and small 5’ and 3’ untrans-
lated regions, into the BamHI site of pSG5. pEGFP-Fer
(WT), pEGFP-Fer (MT D742R) and RhoGDIa have
been previously described [17,18]. The N- and C-term-
inal fragments of RhoGDIa were subcloned from
pEGFP-RhoGDIa-NT and pEGFP-RhoGDIa-CT into
pcDNA3.1/HisB by digestion with EcoRI/XbaI and have
Figure 2 Activation of Fer and non-oncogenic Src. (A) RhoGDIa
was expressed alone or with c-Src as indicated above the panel.
Cells in lanes marked with a “+” were stimulated with H2O2 (10 mM)
for 15 minutes and RhoGDIa was immunoprecipitated. Anti-
phosphotyrosine (pY20) blots were stripped and re-probed with
RhoGDIa antibodies (Santa Cruz). (B) Mouse embryonic fibroblasts
(MEFs), mouse endothelial cells and cells transfected with Fer were
treated with 5 mM of H2O2 for the indicated time. Fer protein was
immunoprecipitated from the lysates followed by a pY20
immunoblot to detect activated tyrosine phosphorylated Fer
(Abcam). (C) COS-1 cells transfected with Xpress-tagged RhoGDIa
were stimulated or not with H2O2, as indicated below the panels.
RhoGDIa antibodies (Upstate Biotechnology) were used for
immunoprecipitation. Antibodies used for Western blotting are
indicated to the left of the panels. Fer, CH-6 antibodies. This result is
representative of two independent experiments.
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Page 4 of 7been previously described [18]. p-LNCX mouse c-Src was
obtained from Addgene (Cambridge, MA).
Recombinant proteins
A fragment containing the start codon of human Fer
(5’-ggggatccatggggtttgggagtgacctg) was used to introduce
a BamHI site immediately 5’ to the Fer ATG. A 155 bp
fragment amplified with this primer and a 3’ oligonucleo-
tide was digested with BamHI × NsiI and the 5’ BamHI-
NsiI fragment ligated with a 3’ 1.2 kb NsiI-KpnI frag-
ment isolated from plasmid Fer SV-7-2 [19] into pSK
digested with BamHI × KpnI. A 1.4 kb BamHI-KpnI
fragment from this plasmid was ligated with a 1.3 kb
KpnI-EcoRI fragment into the pAcG2T baculovirus
transfer vector digested with BamHI × EcoRI. S. frugi-
perda S f 9c e l l sw e r eg r o w ni nG r a c e ’s Insect medium
(Invitrogen) with 10% FBS (heat-inactivated) and 10 μg/
ml Gentamycin (Invitrogen). DNA transfections used 0.5
μg BaculoGold viral DNA and 2 μg of recombinant
baculovirus transfer vector. Three rounds of viral amplifi-
cation were performed and the third amplification used
for large-scale infection and baculovirus production. GST
fusion proteins were purified by glutathione-agarose.
GST-Fer was washed and concentrated using a Centri-
con-10 (Amicon) filter. Bacterially expressed RhoGDIa
and Rac1 were prepared as previously described, with the
GST tag removed from the Rac1 protein by thrombin
cleavage [18].
Cell lines and immunoprecipitations
COS-1 cells and rat basophilic leukemia/mast cell RBL-
2H3 cells were obtained from the ATCC (Rockville, MD).
All tissue culture media and supplements were from Invi-
trogen (Carlsbad, CA). COS-1 cells were cultured in
DMEM or RPMI containing 10% fetal bovine serum
(FBS), penicillin (100 U/ml), streptomycin (100 μg/ml),
L-glutamine and sodium pyruvate (1 mM). RBL-2H3
cells were cultured in MEM containing 15% FBS, 1%
penicillin/streptomycin. Immunoprecipitations and
immunoblotting were performed as described before [18].
Immunocomplex kinase assay
The kinase activity of Fer or Bcr/Abl was measured as
described previously [18]. Briefly, Fer-transfected COS-1
Figure 3 C-terminal end of RhoGDIa is tyrosine phosphorylated. (A) RhoGDIa was expressed alone or with pEGFP-tagged Fer as indicated
above the panel. Cells were stimulated with pervanadate (0.5 mM H2O2 + 0.5 mM vanadate) (+) and RhoGDIa was immunoprecipitated. pY20
blots were stripped and re-probed with GFP or RhoGDIa antibodies. Antibodies used for detection are indicated below the panels. (B) Xpress-
tagged C-terminal RhoGDIa (CT) was expressed alone or together with pEGFP-tagged Fer. Cells were stimulated with pervanadate for 5 minutes.
Results are representative of three independent experiments. (C). RBL-2H3 cells were treated with pervanadate for 5 minutes (+) as indicated and
endogenous RhoGDIa was immunoprecipitated. Western blots were reacted with antibodies against RhoGDIa or phosphotyrosine. The RhoGDIa
antibody was from Santa Cruz.
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HCl, pH 8.0, 150 mM NaCl, 1% Igepal, 0.5% deoxycho-
late, 0.1% SDS, 5 mM EDTA) containing PMSF, leu-
peptin, and aprotinin and then incubated with Fer
antibody, CH-6 for 2 h at 4°C. After incubation with
protein A agarose for 30 min at 4°C, the affinity com-
plex was washed with ice-cold high salt HNTG buffer
(80 mM HEPES, pH 7.5, 0.1% Triton-X100, 500 mM
NaCl and 10% glycerol) and then with ice-cold low salt
HNTG buffer (80 mM HEPES, pH 7.5, 0.1% Triton-
X100, 150 mM NaCl and 10% glycerol). For kinase
reactions, 10 μlo f4 0m MP I P E Sa n d1 0μlo f4 0m M
MnCl2 were added as well as 0.5 μg of GST-RhoGDIa
protein or GST protein. The reactions were initiated
by addition of 10 μCi of [g
32P]ATP (5000 Ci/mmol)
(Amersham). After 40 min on ice, reactions were ter-
minated by the addition of 2× SDS-sample buffer and
boiling for 5 min. Samples were run on 8% SDS-PAGE
gels and the radioactively labeled proteins visualized by
autoradiography.
In vitro binding assay for interaction of RhoGDIa and
Rac1
To investigate possible binding of phosphorylated-
RhoGDIa to Rac1, GST-RhoGDIa protein (50 pmol)
was first combined with GST-Fer (25 pmol) or GST
alone (25 pmol) in 100 μlo fk i n a s eb u f f e r( 2 0m M
HEPES, pH 7.5, 50 mM NaCl, 25 mM MnCl2,1 0m M
MgCl2,1m MD T T ) .2 0μM of ATP was added to the
mixture, which was incubated for 30 min at 4°C for the
kinase reaction. Next, 400 μl of binding buffer (1×
DPBS, 0.1% IgePal, 10% glycerol, 0.5 mM DTT contain-
ing the protease inhibitors PMSF, leupeptin, and aproti-
nin) and 50 pmol Rac1 protein were added, followed by
incubation for 1 h at 4°C. Incubation with antibody
against RhoGDIa for 1 h at 4°C was followed by Protein
A agarose addition and a second incubation 1 h at 4°C.
To investigate if phosphorylation of RhoGDIa by Fer
releases Rac1, GST-RhoGDIa protein was incubated
with Rac1 in binding buffer for 1 h at 4°C; GST-Fer or
GST alone was added, and a pull down with glutathione
agarose was done, followed by washing of the precipi-
tate. Kinase reactions were initiated by addition of
kinase buffer and ATP for 30 min at 4°C.
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Figure 4 Fer interferes with binding of RhoGDIa and Rac.( A )
GST-RhoGDIa was pre-incubated with Rac, after which GST-Fer (G-
Fer) or GST (G) was added and GST fusion proteins were pulled
down with glutathione agarose, followed by kinase reactions. (B)
GST-RhoGDIa was pre-incubated with GST-Fer or GST in kinase
buffer, after which Rac was added and RhoGDIa was
immunoprecipitated. 50 pmol of RhoGDIa and Rac1, with 25 pmol
of GST and GST-Fer were used. Blots were reacted with Rac1
antibodies or pY20, then stripped and reacted with GST antibodies.
This result is representative of two independent experiments.
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